WallStreetZen

NYSE: ABT
Abbott Laboratories Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ABT

Based on 10 analysts offering 12 month price targets for Abbott Laboratories.
Min Forecast
$101.00-16.46%
Avg Forecast
$123.00+1.74%
Max Forecast
$140.00+15.8%

Should I buy or sell ABT stock?

Strong Buy
Strong Buy
5 analysts 50%
Buy
4 analysts 40%
Hold
1 analysts 10%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

ABT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Anonymous
Morgan Stanley
Strong BuyMaintains$136.00+12.49%2021-01-28
Marie Thibault
BTIG
Strong BuyUpgrades$140.00+15.80%2021-01-28
Matthew Taylor
UBS
Strong BuyMaintains$109.00-9.84%2020-04-17
Joanne Wuensch
Citigroup
Strong BuyMaintains$109.00-9.84%2020-04-17
Larry Biegelsen
Wells Fargo
Strong BuyMaintains$107.00-11.50%2020-04-17
Jayson Bedford
Raymond James
BuyMaintains$130.00+7.53%2021-03-11
Joshua Jennings
Cowen & Co.
BuyMaintains$140.00+15.80%2021-01-28
Matt Miksic
Credit Suisse
BuyMaintains$130.00+7.53%2021-01-28
Kevin Huang
CFRA
BuyMaintains$101.00-16.46%2020-04-16
Danielle Antalffy
SVB Leerink
HoldMaintains$128.00+5.87%2021-01-28

1 of 1

Forecast return on equity

Is ABT forecast to generate an efficient return?
Company
34.21%
Industry
-113.33%
Market
32,369.88%
ABT's Return on Equity is forecast to be high in 3 years (34.21%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is ABT forecast to generate an efficient return on assets?
Company
15.56%
Industry
14.17%
Market
11,660.33%
ABT is forecast to generate higher Return on Assets (15.56%) than the US Medical Devices industry average (14.17%)
Forecast

ABT earnings per share forecast

What is ABT's earnings per share in the next 3 years based on estimates from 10 analysts?
Avg 1 year Forecast
$5.07+101.11%
Avg 2 year Forecast
$5.33+111.42%
Avg 3 year Forecast
$5.95+136.11%
ABT's earnings are forecast to grow at an exceptional rate of 32.12% per year
Forecast

ABT revenue forecast

What is ABT's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$42.4B+22.59%
Avg 2 year Forecast
$42.3B+22.31%
Avg 3 year Forecast
$44.6B+28.88%
ABT's revenue is forecast to grow at a rate of 8.21% per year, which is not exceptional
Forecast

ABT earnings growth forecast

How is ABT forecast to perform vs Medical Devices companies and vs the US market?
Company
32.12%
Industry
26.34%
Market
23.13%
ABT's earnings are forecast to grow faster (32.12% per year) than the US Medical Devices industry average (26.34%)
Forecast
ABT's earnings are forecast to grow faster (32.12% per year) than the US market average (23.13%)
Forecast
ABT's earnings are forecast to grow faster (32.12% per year) than the risk-free savings rate (1.7%)
Forecast

ABT revenue growth forecast

How is ABT forecast to perform vs Medical Devices companies and vs the US market?
Company
8.21%
Industry
11.12%
Market
15.05%
ABT's revenues are forecast to grow slower (8.21% per year) than the US Medical Devices industry average (11.12%)
Forecast
ABT's revenues are forecast to grow slower (8.21% per year) than the US market average (15.05%)
Forecast

Abbott Laboratories Stock Forecast FAQ

Is Abbott Laboratories Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NYSE: ABT) stock is to Strong Buy ABT stock.

Out of 10 analysts, 5 (50%) are recommending ABT as a Strong Buy, 4 (40%) are recommending ABT as a Buy, 1 (10%) are recommending ABT as a Hold, 0 (0%) are recommending ABT as a Sell, and 0 (0%) are recommending ABT as a Strong Sell.

What is ABT's earnings growth forecast for 2021-2023?

(NYSE: ABT) Abbott Laboratories's forecast annual earnings growth rate of 32.12% is forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 26.34%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 23.13%.

Abbott Laboratories's earnings in 2021 is $4,495,000,000.On average, 10 Wall Street analysts forecast ABT's earnings for 2021 to be $8,982,328,493, with the lowest ABT earnings forecast at $8,861,807,905, and the highest ABT earnings forecast at $9,287,174,684. On average, 9 Wall Street analysts forecast ABT's earnings for 2022 to be $9,442,788,031, with the lowest ABT earnings forecast at $7,443,918,640, and the highest ABT earnings forecast at $9,978,395,701.

In 2023, ABT is forecast to generate $10,545,551,407 in earnings, with the lowest earnings forecast at $10,350,591,633 and the highest earnings forecast at $10,651,893,102.

What is ABT's revenue growth forecast for 2021-2023?

(NYSE: ABT) Abbott Laboratories's forecast annual revenue growth rate of 8.21% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 11.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.05%.

Abbott Laboratories's revenue in 2021 is $34,608,000,000.On average, 7 Wall Street analysts forecast ABT's revenue for 2021 to be $75,194,834,534,421, with the lowest ABT revenue forecast at $74,483,495,441,525, and the highest ABT revenue forecast at $77,383,078,988,041. On average, 7 Wall Street analysts forecast ABT's revenue for 2022 to be $75,021,953,068,725, with the lowest ABT revenue forecast at $72,769,621,792,698, and the highest ABT revenue forecast at $79,169,619,461,689.

In 2023, ABT is forecast to generate $79,054,905,130,720 in revenue, with the lowest revenue forecast at $76,606,483,314,094 and the highest revenue forecast at $83,121,985,787,319.

What is ABT's forecast return on assets (ROA) for 2021-2024?

(NYSE: ABT) forecast ROA is 15.56%, which is higher than the forecast US Medical Devices industry average of 14.17%.

What is ABT's Price Target?

According to 10 Wall Street analysts that have issued a 1 year ABT price target, the average ABT price target is $123.00, with the highest ABT stock price forecast at $140.00 and the lowest ABT stock price forecast at $101.00.

On average, Wall Street analysts predict that Abbott Laboratories's share price could stay at $123.00 by Mar 11, 2022. The average Abbott Laboratories stock price prediction forecasts a potential downside of N/A from the current ABT share price of $120.90.

What is ABT's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: ABT) Abbott Laboratories's current Earnings Per Share (EPS) is $2.52. On average, analysts forecast that ABT's EPS will be $5.07 for 2021, with the lowest EPS forecast at $5.00, and the highest EPS forecast at $5.24. On average, analysts forecast that ABT's EPS will be $5.33 for 2022, with the lowest EPS forecast at $4.20, and the highest EPS forecast at $5.63. In 2023, ABT's EPS is forecast to hit $5.95 (min: $5.84, max: $6.01).

What is ABT's forecast return on equity (ROE) for 2021-2024?

(NYSE: ABT) forecast ROE is 34.21%, which is considered strong.
©2021 WallStreetZen
Company
AboutBlogPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.